John D. Carpten, PhD, inducted into the 2023 National Academy of Medicine
John D. Carpten, Ph.D., one of the founding MPIs for CaRE2, is a 2023 inductee into the National Academy of Medicine. We are so proud of Dr. Carpten!!🎉👏🥼 Read more here: https://ow.ly/6nh450PUK57.
Indigenous People’s Day
CaRE2 celebrates Indigenous People’s Day! We recognize our CaRE2 members and their strides in research for Indigenous People. They have published 30+ research papers; a few can be found here. Great work!! We recognize: Drs. Scarton, Soto, Begay, Marconett, Webb, and Mason #IndigenousPeoplesDay #IndigenousPeoplesResearch #CaRE2HEC
National Liver Cancer Awareness Month
October is National Liver Cancer Awareness Month. Latinos suffer two times higher rates of liver cancer than their white peers (American Cancer Society). Join us in making a difference in cancer health disparities! 🎗 Octubre es el Mes Nacional de Concienciación sobre el Cáncer de Hígado. Los latinos padecen dos veces más de cáncer de […]
CaRE2 at AACR
CaRE2 enjoyed the AACR Cancer Health Disparities Conference in Orlando, FL! Our team was able to thrive in this environment as they networked, learned, and built new collaborations. Our PI was the conference co-chair, along with several other leaders as session chairs, planning committee, and presenting oral and poster presentations. We even had a whole […]
Cancer Terminology Thursday / Jueves de Terminología del Cáncer
It’s Cancer Terminology Thursday! This week’s term is bilateral. 📚🔬🧬🩺 Feliz Jueves de terminología del cáncer! El término de esta semana es bilateral. 📚🔬🧬🩺 #CaRE2#CancerHealthEquity#CancerResearch#InvestigacíonSobreelCáncer
Congratulations Dr. Gbadamosi – $1.25 million grant
Congratulations to Dr. Gbadamosi on receiving the Early Independence Award from The National Institutes of Health Common Fund; he is 1 of 13 recipients. The award will provide Dr. Gbadamosi with up to $1.25 million over five years to establish his research program, entitled “Decoding the Heterogeneity in Chemo-Immunomodulation to Unlock the Potential of Chemoimmunotherapy […]
Trainees at AACR
Our CaRE2 trainees and early stage investigators had a great time at AACR! Several presented posters, had speaking engagements, and were session co-chairs. We are so proud of your efforts towards reducing cancer health disparities🎉👏
Congratulations to all of our trainees!
Congratulations to our CaRE2 trainees who have recently progressed in their careers!👏 Learn more about our CaRE2 educational programs on our website: ow.ly/oum050PPTCt #CaRE2HEC #CancerResearch #EducationandResearch #TrainingTuesday
CaRE2 has BIG news!
We are excited to share that our CaRE2 Health Equity Center has been funded for another 5 years🎉👏 We cannot wait to continue our work to reduce cancer health disparities🥼 #NCI#CRCHD#PACHE#CancerResearch#CaRE2HealthEquity
CaRE2 at 2023 AACR Cancer Health Disparities
CaRE2 is excited to announce that several of our Center Trainees and ESI have been recognized by #AACR for their work, receiving awards or being selected for oral presentations of their abstracts. We are proud to support such talented researchers. #cancerresearch #healthquity #aacrchd2023
